SHANGHAI JUNSHI BIOSCIENCES CO LTD revenue breakdown overview

SHANGHAI JUNSHI BIOSCIENCES CO LTD revenue for the last year amounted to 2.07 B HKD, the most of which — 2.11 B HKD — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 1.66 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI JUNSHI BIOSCIENCES CO LTD 2.01 B HKD, and the year before that — 1.28 B HKD.